Cabaletta Bio, Inc.
CABANasdaqCIK 1759138HealthcareFiscal year ends Dec 31
Reports and events: 140 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-01-1007:56 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-005100 |
| 2021-12-1407:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-356168 |
| 2021-11-0316:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-133670 |
| 2021-11-0107:37 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-053043 |
| 2021-11-0107:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-314433 |
| 2021-09-0916:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-114209 |
| 2021-08-1807:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-249668 |
| 2021-08-0507:58 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-041196 |
| 2021-08-0507:41 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-237002 |
| 2021-06-2808:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-201119 |
| 2021-06-0306:30 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-180577 |
| 2021-05-0307:24 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-022689 |
| 2021-05-0307:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-146616 |
| 2021-04-2116:10 ET | DEF 14A | Proxy statementPeriod 2021-06-01 | 0001193125-21-124695 |
| 2021-04-0606:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-106915 |
| 2021-03-1608:15 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-013329 |
| 2021-03-1607:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-082134 |
| 2021-01-1217:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-21-003503 |
| 2020-12-1417:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-20-135319 |
| 2020-12-0816:35 ET | 8-K | 8.01 Other events | 0001193125-20-312789 |
| 2020-11-1008:40 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052757 |
| 2020-11-1008:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-289674 |
| 2020-08-0608:13 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-037278 |
| 2020-08-0607:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-211336 |
| 2020-06-0306:07 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-159049 |
| 2020-05-2808:08 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-153792 |
| 2020-05-1210:57 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-024508 |
| 2020-05-1207:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-139782 |
| 2020-05-0608:17 ET | 8-K | 8.01 Other events | 0001193125-20-134391 |
| 2020-04-2307:00 ET | DEF 14A | Proxy statementPeriod 2020-06-02 | 0001193125-20-115863 |
| 2020-03-3010:37 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-013929 |
| 2020-03-3007:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-090013 |
| 2020-02-2007:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-042689 |
| 2020-01-2908:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-017724 |
| 2020-01-1009:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-005110 |
| 2019-12-0516:28 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-045375 |
| 2019-11-1208:34 ET | SC 13D | Ownership report, active investor | 0001104659-19-061822 |
| 2019-10-3016:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-19-278927 |
| 2019-10-1607:58 ET | S-1/A | Registration statement, amended | 0001193125-19-268040 |
| 2019-09-3016:50 ET | S-1 | Registration statement | 0001193125-19-258869 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:57 ET. Listed shows no prices and gives no investment advice.